Diagnosis and classification of ATL
Subtype . | Asymptomatic HTLV-1 carrier . | Smoldering . | Chronic . | Acute . | Lymphoma . |
---|---|---|---|---|---|
HTLV-1 serology | + | + | + | + | + |
Monoclonal integration of provirus | − | + | + | + | + (lymph node) |
Lymphocyte count | Normal | Normal | Elevated | Elevated | Normal |
Percentage circulating abnormal lymphocytes | <5% | ≥5% or <5% if ATL skin and lung lesions present | ≥5% | ≥5% | ≤1% |
Hypercalcemia | − | − | − | Normal or high | Normal or high |
LDH | Normal | Normal or ≤1.5 ULN | Normal or <2 ULN | Normal or high | Normal or high |
Skin or lung involvement | − | + | + | + | + |
Bone marrow or splenic involvement | − | − | + | + | + |
Bone, gastrointestinal, or CNS involvement | − | − | − | + | + |
Subtype . | Asymptomatic HTLV-1 carrier . | Smoldering . | Chronic . | Acute . | Lymphoma . |
---|---|---|---|---|---|
HTLV-1 serology | + | + | + | + | + |
Monoclonal integration of provirus | − | + | + | + | + (lymph node) |
Lymphocyte count | Normal | Normal | Elevated | Elevated | Normal |
Percentage circulating abnormal lymphocytes | <5% | ≥5% or <5% if ATL skin and lung lesions present | ≥5% | ≥5% | ≤1% |
Hypercalcemia | − | − | − | Normal or high | Normal or high |
LDH | Normal | Normal or ≤1.5 ULN | Normal or <2 ULN | Normal or high | Normal or high |
Skin or lung involvement | − | + | + | + | + |
Bone marrow or splenic involvement | − | − | + | + | + |
Bone, gastrointestinal, or CNS involvement | − | − | − | + | + |
−, negative; +, positive; CNS, central nervous system; ULN, upper limit of normal.